Clinical Trials

NCT05005403 | RECRUITING | PHASE1
694 participants

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-23
Start Date:
2021-11-01
Completion:
2027-07-31
Conditions
  • Non-Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Micro Satellite Stable Colorectal Cancer
  • Gastric/Esophageal Cancer
  • High-Grade Serous Ovarian Cancer
  • Pancreatic Cancer
  • Triple Negative Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT04947254 | RECRUITING | PHASE2
200 participants

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-23
Start Date:
2021-08-05
Completion:
2028-06-07
Conditions
  • Prostate Carcinoma
  • Stage IIC Prostate Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IIIA Prostate Cancer AJCC v8
  • Stage IIIB Prostate Cancer AJCC v8
  • Stage IIIC Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • RADIATION
No Results Yet
NCT04929392 | ACTIVE_NOT_RECRUITING | PHASE2
3 participants

Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-23
Start Date:
2022-01-25
Completion:
2022-12-09
Conditions
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Esophageal Adenocarcinoma
  • Esophageal Squamous Cell Carcinoma
  • Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • RADIATION
  • BIOLOGICAL
NCT04869111 | RECRUITING | NA
100000 participants

The BrainHealth Project

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-23
Start Date:
2020-08-01
Completion:
2038-08-01
Conditions
  • Healthy
Interventions
  • BEHAVIORAL
No Results Yet
NCT04764175 | ACTIVE_NOT_RECRUITING | NA
500 participants

Telephone All Nations Breath of Life

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-23
Start Date:
2021-05-13
Completion:
2026-07-31
Conditions
  • Smoking Cessation
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page